Event Group

Event Group

Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.

Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.

Event Group path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Group

Event Group


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-25 @ 2:41 PM
NCT ID: NCT03103750
Group ID: EG000
Title: Calcitriol Then Placebo
Description: Healthy volunteers will receive a baseline MRI. On the night before and day of testing, subjects will receive two doses of calcitriol (3.0mcg total), followed by PHNO injection and PET Scan #1. After PET Scan #1, subjects will receive a Dexedrine dose, followed by PHNO injection and PET Scan #2. A minimum of six days later, subjects will receive two doses of placebo for the night before and day of testing, followed by a third PHNO injection and PET scan #3. After PET scan #3, subjects will receive another Dexedrine dose, followed by PHNO injection and PET scan #4. Magnetic Resonance Imaging (MRI): Magnetic resonance imaging (MRI) scans (3 T) will be collected in each subject for the purposes of excluding participants with anatomical abnormalities and anatomically co-registering PET and MRI for image analysis PHNO: Used as a tracer for in vivo imaging. calcitriol: three 0.5 mcg capsules Placebo oral capsule: three 0.5 mcg capsules high-resolution research tomography: A functional imaging technique that is used to observe metabolic processes in the body. Dextro Amphetamine: Dexedrine 0.3 mg/kg, to a maximum dose of 30 mg
Deaths Number Affected: 0
Deaths Number At Risk: None
Serious Number Affected: 0
Serious Number At Risk: 12
Other Number Affected: 7
Other Number At Risk: 12
Study: NCT03103750
Results Section: NCT03103750
Adverse Events Module: NCT03103750